ALEXZA PHARMACEUTICALS, INC.

Inactive Instrument

Alexza Pharmaceuticals, Inc. Share Price

Equities

US0153842093

Biotechnology & Medical Research

End-of-day quote Nasdaq Other stock markets
- ^USD	-

on all our subscriptions*

Take advantage of the offer

* See conditions on site

Press releases Alexza Pharmaceuticals, Inc.

Alexza Pharmaceuticals : Reports Fourth Quarter and Year End 2015 Financial Results	29/16/29	PU
Alexza Pharmaceuticals : to Report 2015 Year End Financial Results and Provide Company Update on Monday, March 28, 2016	16/16/16	PU
Alexza Pharmaceuticals : Receives Positive Nasdaq Listing Determination	10/16/10	PU
Alexza Pharmaceuticals : Confirms Grupo Ferrer Non-binding Letter of Intent	27/16/27	PU
Alexza Pharmaceuticals : Reacquires U.S. Commercial Rights for ADASUVE® (loxapine) inhalation powder	24/16/24	PU

More press releases

News in other languages on Alexza Pharmaceuticals, Inc.

Alexza Pharmaceuticals : Les valeurs à suivre sur les marchés américains

22/15/22

Managers and Directors - Alexza Pharmaceuticals, Inc.

Managers	Title	Age	Since
Stacy Palermini DFI	Director of Finance/CFO	-	01/03/01
Tatjana Naranda PSD	President	-	01/05/01
Wolfgang Schmidt PRN	Corporate Officer/Principal	-	01/19/01

Members of the board	Title	Age	Since
Jorge Ramentol Massana BRD	Director/Board Member	-	21/16/21
Joan Fanés Trillo BRD	Director/Board Member	-	21/16/21
Sergio Ferrer-Salat Serra di Migni BRD	Director/Board Member	-	21/16/21

Company Profile

Sector

Biotechnology & Medical Research

More about the company

Sector Bio Therapeutic Drugs

	1st Jan change	Capi.
VERTEX PHARMACEUTICALS INCORPORATED	+3.91%	109B
REGENERON PHARMACEUTICALS, INC.	+10.87%	105B
ARGENX SE	+1.28%	22.25B
BIONTECH SE	-13.14%	22.09B
GENMAB A/S	-7.05%	18.68B
WUXI APPTEC CO., LTD.	-38.36%	17.58B
BEIGENE, LTD.	-10.66%	16.85B
NEUROCRINE BIOSCIENCES, INC.	+3.75%	13.76B
SAREPTA THERAPEUTICS, INC.	+36.70%	12.46B

Bio Therapeutic Drugs

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW